This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Methylnaphthidate: Difference between revisions
>Unity |
>Josikins No edit summary |
||
| Line 16: | Line 16: | ||
==Pharmacology== | ==Pharmacology== | ||
Methylnaphthidate is thought to act primarily as a [[monoamine]] triple [[reuptake inhibitor]], meaning it effectively boosts the levels of [[dopamine]], [[noradrenaline]] and [[serotonin]] [[neurotransmitters]] throughout the brain by binding to and partially blocking the transporter proteins that normally clear these monoamines from the synaptic cleft. This allows these molecules to accumulate throughout the brain, particularly within the reward pathways in the brain, resulting in stimulating and euphoric effects. | Methylnaphthidate is thought to act primarily as a [[monoamine]] triple [[reuptake inhibitor]], meaning it effectively boosts the levels of [[dopamine]], [[noradrenaline]] and [[serotonin]] [[neurotransmitters]] throughout the brain by binding to and partially blocking the transporter proteins that normally clear these monoamines from the synaptic cleft. This allows these molecules to accumulate throughout the brain, particularly within the reward pathways in the brain, resulting in stimulating and euphoric effects. | ||